Cargando…

Adult Primary Retroperitoneal Lymphangioma: Updated Facts

Lymphangioma is a rare, benign tumor of the lymphatic system. It is believed to be a congenital malformation, when part of the lymphatic channels fail to connect to the main lymphatic system. Lymphangioma is a tumor of the pediatric age, with 50% of patients presenting at birth. The head and neck ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansour, Subhi, Kluger, Yoram, Khuri, Safi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990737/
https://www.ncbi.nlm.nih.gov/pubmed/36896002
http://dx.doi.org/10.14740/wjon1561
_version_ 1784901998330511360
author Mansour, Subhi
Kluger, Yoram
Khuri, Safi
author_facet Mansour, Subhi
Kluger, Yoram
Khuri, Safi
author_sort Mansour, Subhi
collection PubMed
description Lymphangioma is a rare, benign tumor of the lymphatic system. It is believed to be a congenital malformation, when part of the lymphatic channels fail to connect to the main lymphatic system. Lymphangioma is a tumor of the pediatric age, with 50% of patients presenting at birth. The head and neck are the main affected sites (75%), while the retroperitoneal cavity is the least affected area, and comprises less than 1% of cases. Adult lymphangioma is an extremely rare tumor, and adult retroperitoneal lymphangioma (ARL) is even a rarer tumor. Over the last two decades, we have experienced a significant increase in reports published in the English literature discussing ARL. As reports have increased, several questions about previously known facts regarding this tumor arose: For years, it was known that ARL is usually an asymptomatic tumor which is incidentally found - is it a true claim? Is abdominal magnetic resonance imaging the radiological test of choice for diagnosis? What is the best therapeutic option? The main aim for this article is to review the current and old English literature concerning ARL, in order to collect data regarding demographic features, clinical presentation, imaging tests used for diagnosis, therapeutic options and follow-up. This in turn will give precise updated answers for the previous questions. In addition, it will raise awareness for the treating physician regarding the most effective approach for early diagnosis and best therapeutic option to be selected.
format Online
Article
Text
id pubmed-9990737
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-99907372023-03-08 Adult Primary Retroperitoneal Lymphangioma: Updated Facts Mansour, Subhi Kluger, Yoram Khuri, Safi World J Oncol Review Lymphangioma is a rare, benign tumor of the lymphatic system. It is believed to be a congenital malformation, when part of the lymphatic channels fail to connect to the main lymphatic system. Lymphangioma is a tumor of the pediatric age, with 50% of patients presenting at birth. The head and neck are the main affected sites (75%), while the retroperitoneal cavity is the least affected area, and comprises less than 1% of cases. Adult lymphangioma is an extremely rare tumor, and adult retroperitoneal lymphangioma (ARL) is even a rarer tumor. Over the last two decades, we have experienced a significant increase in reports published in the English literature discussing ARL. As reports have increased, several questions about previously known facts regarding this tumor arose: For years, it was known that ARL is usually an asymptomatic tumor which is incidentally found - is it a true claim? Is abdominal magnetic resonance imaging the radiological test of choice for diagnosis? What is the best therapeutic option? The main aim for this article is to review the current and old English literature concerning ARL, in order to collect data regarding demographic features, clinical presentation, imaging tests used for diagnosis, therapeutic options and follow-up. This in turn will give precise updated answers for the previous questions. In addition, it will raise awareness for the treating physician regarding the most effective approach for early diagnosis and best therapeutic option to be selected. Elmer Press 2023-02 2023-02-26 /pmc/articles/PMC9990737/ /pubmed/36896002 http://dx.doi.org/10.14740/wjon1561 Text en Copyright 2023, Khuri et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Mansour, Subhi
Kluger, Yoram
Khuri, Safi
Adult Primary Retroperitoneal Lymphangioma: Updated Facts
title Adult Primary Retroperitoneal Lymphangioma: Updated Facts
title_full Adult Primary Retroperitoneal Lymphangioma: Updated Facts
title_fullStr Adult Primary Retroperitoneal Lymphangioma: Updated Facts
title_full_unstemmed Adult Primary Retroperitoneal Lymphangioma: Updated Facts
title_short Adult Primary Retroperitoneal Lymphangioma: Updated Facts
title_sort adult primary retroperitoneal lymphangioma: updated facts
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990737/
https://www.ncbi.nlm.nih.gov/pubmed/36896002
http://dx.doi.org/10.14740/wjon1561
work_keys_str_mv AT mansoursubhi adultprimaryretroperitoneallymphangiomaupdatedfacts
AT klugeryoram adultprimaryretroperitoneallymphangiomaupdatedfacts
AT khurisafi adultprimaryretroperitoneallymphangiomaupdatedfacts